Tilray shares are about to make a bounce back up. The shares have taken a 70% haircut in 2019, we think it's time to get back in to this stock.
"Tilray sold $15.8 million worth of recreational weed. International medical cannabis sales increased to $5.7 million from $949,000 a year ago. Tilray Chief Executive Brendan Kennedy said in an interview with MarketWatch that he attributes the international cannabis sales to investments the company made in 2017 and 2018 that are now beginning to bear fruit."
marketwatch.com/story/tilray-earnings-show-pot-sales-quintupling-beating-expectations-2019-11-12
finance.yahoo.com/news/tilray-options-traders-call-short-165728411.html
"Tilray sold $15.8 million worth of recreational weed. International medical cannabis sales increased to $5.7 million from $949,000 a year ago. Tilray Chief Executive Brendan Kennedy said in an interview with MarketWatch that he attributes the international cannabis sales to investments the company made in 2017 and 2018 that are now beginning to bear fruit."
marketwatch.com/story/tilray-earnings-show-pot-sales-quintupling-beating-expectations-2019-11-12
finance.yahoo.com/news/tilray-options-traders-call-short-165728411.html
免責聲明
這些資訊和出版物並非旨在提供，也不構成TradingView提供或認可的任何形式的財務、投資、交易或其他類型的建議或推薦。請閱讀使用條款以了解更多資訊。
免責聲明
這些資訊和出版物並非旨在提供，也不構成TradingView提供或認可的任何形式的財務、投資、交易或其他類型的建議或推薦。請閱讀使用條款以了解更多資訊。